INNOVADERM CRO IS NOW INDERO.
circle

Acne Case Study

Indero

Indero

Team of Experts

Outcomes

  • Innovaderm successfully managed this acne study and this resulted in enrollment completed 1 month earlier than planned

Study Characteristics

  • Study Phase: II
  • Patient Population: Acne vulgaris (enrolling pediatrics & adults)
  • IP Route of Administration: Systemic
  • Sites distribution: 15 sites (USA)

Study Challenges and Solutions

Challenge 1: Administration Mode

Use of a novel route of administration for a population accustomed to topical and oral treatments

Solutions

  • Promoting the new treatment and clarity of messaging with the sites
  • Careful selection of sites

Outcome

  • Enrollment completed one month ahead of schedule

Challenge 2: Recruitment – Apprehension

  • Enrollment of pediatric population while managing patients’ and their parents’ fears regarding the route of administration

Solutions

  • Experience with pediatric enrollment was mandatory for sites
  • As minors tend to have compliance issues, the administration of a drug once every two weeks was a key advantage

Outcome

  • Recruited much more pediatrics than expected (+40%)

Challenge 3: Pandemic

  • Enrolling during the first waves of COVID-19 could have impacted recruitment & operations (site staffing, monitoring visits, etc.)

Solutions

  • Sites were prepared to operate and follow new safety guidelines regarding COVID-19

Outcome

  • The study proceeded as scheduled

Key Success Factors & Strategies

  • Local advertisement campaigns to increase engagement
  • Implemented remote monitoring during COVID-19 to maintain workflow efficiency

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Is Now

We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Additionally, our Clinical Research Unit (CRU) will keep the name Innovaderm and will continue to conduct dermatology studies.

Site Selection & Management

Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.

Hands, tablet and contact us with healthcare marketing or advertising on a website in the medical industry.

Patient Recruitment

Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.